Atlas Trials

Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer

Clinical trial NCT00546156 · COMPLETED

Trial details

NCT number
NCT00546156
Sponsor
Ian E. Krop, MD, PhD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-10-01
Primary completion
2011-10-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.